| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $112.94 | $24.80 | 355.47% | 213.09x | 53.75x | 14.33x | 17.30x | 1.54x | $106.92M | 0.90% | $705.78M | 6.70 | $12.11B | 1,543.28 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.38 | $8.47 | 211.40% | 125.62x | 58.98x | 7.42x | 15.03x | 1.08x | $39.15M | 1.14% | $220.58M | 1.69 | $3.40B | 74.80 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.08 | $17.86 | 325.87% | 71.10x | 65.09x | 7.02x | 9.07x | 1.82x | $182.84M | 3.10% | $654.15M | 8.43 | $5.77B | 48.10 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $246.51 | $83.00 | 197.01% | 40.41x | 36.56x | 6.86x | 24.36x | 1.39x | $793.95M | 2.41% | $1.35B | 10.14 | $34.26B | 29.05 | ||
| HALO | HALOZYME THERAPEUTICS INC | $112.44 | $73.40 | 53.19% | 31.58x | 12.45x | 7.93x | 88.91x | 0.61x | $806.22M | 6.11% | $143.54M | 1.22 | $14.74B | 20.52 | ||
| VCEL | VERICEL CORP | $38.79 | $8.25 | 370.39% | 80.81x | 69.30x | 6.47x | 5.37x | 1.98x | $61.66M | 3.11% | $370.04M | 7.25 | $1.95B | 44.35 | ||
| KRYS | KRYSTAL BIOTECH INC | $341.75 | $86.60 | 294.62% | 41.32x | 43.78x | 22.91x | 7.44x | 2.21x | $257.78M | 2.55% | $1.36B | 46.03 | $9.70B | 41.57 | ||
| RPRX | ROYALTY PHARMA PLC | $57.65 | $37.32 | 54.48% | 30.66x | 10.54x | 10.12x | 3.39x | 0.62x | $2.92B | 11.39% | $9.79B | 21.99 | $41.30B | 35.12 | ||
| TGTX | TG THERAPEUTICS INC | $56.00 | $23.12 | 142.17% | 18.18x | 56.35x | 9.93x | 14.19x | 2.02x | $17.39M | 0.22% | $604.08M | 4.26 | $8.84B | 63.50 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.32 | $7.85 | 44.20% | 11.92x | 10.40x | 4.92x | 3.09x | 1.04x | $82.01M | 12.24% | $217.65M | 3.68 | $528.40M | 6.83 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $62.21 | $19.22 | 223.66% | 163.71x | 21.50x | 3.53x | 1.90x | 1.09x | $738.18M | 6.13% | $6.32B | 32.68 | $15.35B | 39.81 | ||
| MDXG | MIMEDX GROUP INC | $4.77 | $1.31 | 263.24% | 119.25x | -27.51x | 1.99x | 3.22x | 1.29x | $44.50M | 6.31% | $216.00M | 1.46 | $576.64M | 25.28 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $234.88 | $185.94 | 26.32% | 15.39x | 9.19x | 3.23x | 3.18x | 0.63x | $1.62B | 10.91% | $4.80B | 75.98 | $18.02B | 11.15 | ||
| EXEL | EXELIXIS INC | $56.73 | $30.95 | 83.30% | 17.24x | 17.15x | 5.84x | 7.62x | 1.13x | $1.17B | 8.24% | $1.84B | 7.35 | $13.94B | 12.82 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $298.41 | $88.55 | 236.98% | 29.63x | 31.59x | 20.61x | 6.15x | 2.24x | $130.62M | 2.18% | $967.52M | 48.22 | $6.07B | 21.77 | ||
| ADMA | ADMA BIOLOGICS INC | $9.70 | $7.20 | 34.77% | 13.47x | 12.19x | 4.32x | 5.32x | 0.79x | $116.47M | 5.26% | $408.21M | 1.79 | $2.23B | 9.59 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $516.34 | $153.04 | 237.40% | 29.79x | 26.97x | 10.41x | 6.46x | 2.24x | $3.80B | 2.90% | $20.25B | 79.81 | $126.71B | 23.02 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $801.82 | $441.38 | 81.66% | 19.12x | 14.29x | 5.31x | 2.60x | 1.01x | $3.76B | 4.56% | $31.71B | 308.48 | $82.80B | 14.40 | ||
| UTHR | UNITED THERAPEUTICS CORP | $489.42 | $194.56 | 151.55% | 16.18x | 18.31x | 6.61x | 3.28x | 2.97x | $1.09B | 5.24% | $6.40B | 150.24 | $19.19B | 11.45 | ||
| TECH | BIO-TECHNE CORP | $72.52 | $16.80 | 331.76% | 61.98x | 34.90x | 9.31x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.78 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $40.48 | $31.04 | 30.41% | 12.89x | 9.71x | 2.44x | 2.36x | 0.77x | $354.90M | 15.13% | $999.24M | 17.25 | $1.96B | 7.01 | ||
| VCYT | VERACYTE INC | $43.82 | $12.10 | 262.24% | 30.43x | 22.53x | 6.24x | 2.54x | 2.55x | $165.99M | 4.74% | $1.39B | 17.36 | $3.26B | 23.35 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.26 | $1.43 | -12.00% | 9.00x | -2.84x | 1.55x | 1.66x | 0.50x | $19.58M | 26.83% | $44.20M | 0.76 | $24.64M | 3.22 | ||
| INCY | INCYTE CORP | $124.64 | $60.76 | 105.12% | 15.35x | 35.16x | 4.29x | 3.98x | 1.72x | $1.92B | 7.69% | $6.34B | 31.66 | $21.31B | 10.31 |